Edition:
United States

Intra-Cellular Therapies Inc (ITCI.OQ)

ITCI.OQ on NASDAQ Stock Exchange Global Select Market

19.37USD
17 Oct 2018
Change (% chg)

$-0.24 (-1.22%)
Prev Close
$19.61
Open
$19.60
Day's High
$19.60
Day's Low
$18.87
Volume
69,984
Avg. Vol
116,463
52-wk High
$25.74
52-wk Low
$13.93

Chart for

About

Intra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company. The Company is focused on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system... (more)

Overall

Beta: 0.90
Market Cap(Mil.): $1,007.74
Shares Outstanding(Mil.): 54.71
Dividend: --
Yield (%): --

Financials

  ITCI.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -2.43 -- --
ROI: -34.53 1.96 12.83
ROE: -34.80 1.12 14.95

BRIEF-Intra-Cellular Therapies Reports Q1 Loss Per Share $0.65

* INTRA-CELLULAR THERAPIES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 03 2018

Earnings vs. Estimates